lily tirzepatide Eli Lilly wants to replace Zepbound with an even stronger weight loss drug FDA approves Eli Lilly's tirzepatide

Of 152 participants, the average additional weight loss after switching was 2.1 kg over 12 weeks

For most people, burping improves within four to eight weeks at each stable dose as the body adapts

The future we envision will require scientific innovation, clinical collaboration, healthcare system transformation, and patient engagement

The TGA has issued a warning to social media influencers that "large fines and penalties apply to illegal advertising", including the promotion of reta and GLP-1 medications

As patients lose weight on semaglutide, the cardiovascular system often becomes more efficient, which may help lower blood pressure naturally